
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Viruses aren’t all bad: In the ocean, some help fuel the food web – a new study shows how - 2
Instructions to Comprehend and Use Open Record Extra Offers - 3
7 Straightforward Moves toward Move Information from Your Old Cell phone to Your New One: A Thorough Aide - 4
Two IDF officers, civilian face indictment in alleged Gaza aid-truck smuggling scheme - 5
The Delight of Camper Vans: Choosing the One That Meets Your Requirements
The 1 question we have to ask ourselves about the Taylor Frankie Paul 'Bachelorette' scandal
One dead, six wounded in various crime-related shootings in Israel over the weekend
What’s the shadowy organisation taking Gaza Palestinians to South Africa?
Kiefer Sutherland arrested after allegedly assaulting a ride-share driver in L.A.
The moon up close: How the Artemis 2 astronauts are photographing their historic lunar flyby
Why the UAE has incurred the wrath of Somalia
Vote In favor of Your Favored Keeping an eye on
My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs
Hyundai Is Keeping the i30 Alive While America Keeps Losing Cars Like It













